Combination of Topical Use of a Thrombin-Based Hemostatic Matrix and Tranexamic Acid does not have a Synergic Effect on Reducing Postoperative Blood Loss in Minimally Invasive Total Knee Arthroplasty. A Prospective Randomized Controlled Study
نویسندگان
چکیده
Background: There is limited information regarding the blood-conservation effect of combined topical Tranexamic Acid (TXA) and Thrombin-Based Hemostatic Matrix (TBHM) in Total Knee Arthroplasty (TKA). This study to evaluate whether there synergic use TXA TBHM reduce blood loss during TKA. Materials Methods: Sixty-nine patients (69 knees) who underwent primary TKA were randomly assigned into a group (n=34), received intra-articular administration 3g 60mL saline, + (n=35), (3g) saline after The outcomes Blood Loss (TBL) postoperative Hemoglobin (Hb) level. Secondary included transfusion rate incidence Venous Thromboembolism (VTE). Results: mean TBL was 678 ± 203 mL , which similar that only at 733 217 (p=0.276). no differences Hb level between two groups. (2.9% versus 0%, p=0.242). No either developed VTE within 3 months. Conclusions: Our prospective randomized controlled did not show undergoing Further investigation with larger sample size may be required.
منابع مشابه
The Efficacy of Intravenous Versus Topical Use of Tranexamic Acid in Reducing Blood Loss after Primary Total Knee Arthroplasty: A Randomized Clinical Trial
Background: Blood loss during and immediately after total knee arthroplasty (TKA) is among the most challenging concerns. It has been demonstrated that Tranexamic acid (TXA) can help to reduce perioperative blood loss. TXA can be used as an oral, topical or intravenous injection. Many studies evaluated the effectiveness of each route of administration but few works on a comparison between them....
متن کاملTopical Tranexamic Acid Reduces Blood Loss in Minimally Invasive Total Knee Arthroplasty Receiving Rivaroxaban
Background It is unclear whether topical (intra-articular) or intravenous TXA reduces blood loss in minimally invasive TKA patients receiving a direct oral anticoagulant for thromboprophylaxis. This study is to investigate whether TXA given intravenously or intra-articularly is effective in reducing blood loss in minimally invasive TKA patients using rivaroxaban for thromboprophylaxis. Method...
متن کاملTopical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial.
BACKGROUND Topical application of tranexamic acid to bleeding wound surfaces reduces blood loss in patients undergoing some major surgeries, without systemic complications. The objective of the present trial was to assess the efficacy and safety of the topical application of tranexamic acid on postoperative blood loss in patients undergoing primary unilateral total knee arthroplasty with cement...
متن کاملEffect of Tranexamic Acid Use on Postoperative Blood Loss in Total Knee Arthroplasty.
AIM To monitor the effect of tranexamic acid use (Exacyl) on postoperative bleeding (aspiration), autologous blood transfusion (autotransfusion), allogeneic blood transfusion and postoperative anemia (difference between preoperative and immediate postoperative hemoglobin levels) in total knee arthroplasty. MATERIALS AND METHODS This retrospective observational study was conducted on a sample ...
متن کاملTranexamic Acid Reduces Blood Loss and Transfusion in Patients Undergoing Total Knee Arthroplasty without Tourniquet: A Prospective Randomized Controlled Trial
INTRODUCTION Blood loss during and after total knee arthroplasty (TKA) can lead to substantial morbidity and the need for blood transfusions. There are several methods to minimize blood loss and to decrease transfusion rates in patients undergoing TKA. Tranexamic acid is an antifibrinolytic agent with known efficacy for achieving these goals. Currently, many surgeons are performing TKA without ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Thrombosis & haemostasis research
سال: 2021
ISSN: ['2689-9663']
DOI: https://doi.org/10.26420/thrombhaemostres.2021.1066